Get startedLog in
    Picture of Cohance Lifesciences logo

    COHANCE — Cohance Lifesciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Suven Pharmaceuticals Says Pre-Approval Inspections And Good Manufacturing Practices Inspections By USFDA Completes

    Picture of Cohance Lifesciences logoCohance Lifesciences
    23/02/2024 11:09
    Feb 23 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS LTD - COMPLETION OF PRE-APPROVAL
INSPECTIONS (PAI) AND GOOD MANUFACTURING PRACTICES (GMP)
INSPECTIONS BY USFDA
    * SUVEN PHARMACEUTICALS LTD - NO FORM 483 HAS BEEN ISSUED AS
A
RESULT OF THE INSPECTION
    * SUVEN PHARMACEUTICALS LTD -  API FACILITIES IN PASHAMYLARA
COMPLETED PRE- APPROVAL INSPECTIONS AND GOOD MANUFACTURING
PRACTICES INSPECTIONS
    * SUVEN PHARMACEUTICALS LTD -  INSPECTIONS BY US FOOD & DRUG
ADMINISTRATION

Source text for Eikon:  ID:nBSE62GhBW 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Cohance Lifesciences

    See all news